FDA Faces Leadership Shakeup as Vaccine Chief and Top Official Depart

The FDA’s vaccine chief has been ousted for the second time under the Trump administration, highlighting ongoing leadership turmoil. Concurrently, Vinay Prasad, a controversial figure linked to agency controversies, is also leaving the FDA, signaling possible shifts in policy direction. These changes could influence regulatory decisions on vaccines and public health in 2023, warranting close observation of the agency's future leadership and policy stance.
En esta historia
Cronología · 91d ago
90d ago
1 article · NBC News Health
91d ago
1 article · Raw Story
91d ago
1 article · Guardian Health
91d ago
1 article · STAT News
0 Comments
Sign in to join the discussion
No comments yet
Be the first to share your thoughts
More health Stories

Jon Snow, Former Channel 4 News Anchor, Diagnosed with Alzheimer's
health · 5h ago

Ebola Outbreak in Central Africa May Hit 20,000 Cases Without Action
health · 2h ago

Latest medical reports omit Trump’s hair loss medication, raising health concerns
health · 8h ago

Britain's Women Report Highest Anger Levels in European Survey
health · 14h ago

Kevin Warsh sworn in as 17th Fed Chair, signals hawkish stance and pro-crypto views
economics · 2d ago

US and Iran Near Agreement to Reopen Strait of Hormuz Despite US Strikes
world · 8h ago
Vinay Prasad
University of California, San Francisco
Marty Makary
FDA
UniQure
Wall Street Journal
Moderna
United States
Food and Drug Administration
CNN